This study is looking at whether regular blood transfusions can help pregnant women with sickle cell disease (SCD) experience fewer health issues during their pregnancy. SCD is a genetic disorder that makes red blood cells rigid and causes pain and organ damage. For pregnant women with SCD, regular blood transfusions, which involve giving blood from a donor to replace or add to the patient's blood, might prevent problems like preeclampsia, preterm delivery, and growth issues in babies.
Participants will receive either regular blood transfusions or standard care. The study lasts about 8-10 months, covering the pregnancy and two months after delivery. Blood transfusion is the only treatment option for pregnant women with SCD since other medicines might harm the baby.
- Participants will be in the study for about 8-10 months.
- Participants may need regular visits for transfusions.
- The study seeks to find better ways to care for pregnant women with SCD.